UBS downgraded Sonova to Sell from Neutral with a price target of CHF 260, up from CHF 225. the analyst says earnings pressure, reliance on a new product launch, rising competition and a full valuation make for a less appealing risk/reward.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
